ReviewPharmaceutics2022

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Mujeeb Ur Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.